Clinical Trial Update: A Phase 1b/2 Open-label, Dose-ranging Safety and Efficacy Study of Oral Cladribine in Patients With Acute Myeloid Leukemia (AML) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1b/2 open-label study is evaluating the safety and efficacy of oral cladribine in patients with acute myeloid leukemia, with the trial currently not yet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Oral Cladribine (Cladribine)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Acute Myeloid Leukemia (AML) | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING